Treat-to-target SLE strategy in 10 years: Discussion of current limitations and available options for implementation in real-world clinical practice

Menopause and rheumatoid arthritis (up to date)

Effect of interleukin 6 blockers on body composition, adipocytokines and insulin-like growth factor 1 in patients with rheumatoid arthritis

Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: Two-year results of the real word evidence LIBRA study

Prospects of anti-B-cell therapy for systemic sclerosis

Comparative analysis of the functional status of hip joints before total hip replacement in patients with ankylosing spondylitis, rheumatoid arthritis and coxarthrosis: preliminary data of a retrospective study

Treat-to-target SLE strategy in 10 years: Discussion of current limitations and available options for implementation in real-world clinical practice

Menopause and rheumatoid arthritis (up to date)

Effect of interleukin 6 blockers on body composition, adipocytokines and insulin-like growth factor 1 in patients with rheumatoid arthritis

Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: Two-year results of the real word evidence LIBRA study

Prospects of anti-B-cell therapy for systemic sclerosis

Comparative analysis of the functional status of hip joints before total hip replacement in patients with ankylosing spondylitis, rheumatoid arthritis and coxarthrosis: preliminary data of a retrospective study